Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.

Maioli, Mario ; Alejandro, Emilyn ; Tonolo, Giancarlo ; Gilliam, Lisa K. ; Bekris, Lynn ; Hampe, Christiane S. ; Obinu, Domenica A ; Manconi, Alberto ; Puddu, Loreta and Lynch K, Kristian , et al. (2004) In Journal of Clinical Endocrinology and Metabolism 89(11). p.5675-5682
Abstract
The 65-kDa glutamic acid decarboxylase (GAD65) autoantibodies (GAD65Abs), commonly found in type 1 diabetes mellitus (T1DM) patients, are also found at lower frequencies in type 2 diabetes mellitus (T2DM) patients. GAD65Abs in T1DM patients are epitope specific, in contrast to those found in other GAD65Ab-positive individuals, including T2DM patients. Our aim was to assess whether epitope-specific GAD65Abs, or the additional presence of islet antigen 2 (IA-2) autoantibodies, better define T1DM phenotypes among T2DM patients. GAD65 and IA-2 autoantibodies were analyzed in 1436 Sardinian subjects classified with T2DM and in 384 nondiabetic patient controls. Autoantibody binding specificity to the N-terminal, middle (M), and C-terminal (C)... (More)
The 65-kDa glutamic acid decarboxylase (GAD65) autoantibodies (GAD65Abs), commonly found in type 1 diabetes mellitus (T1DM) patients, are also found at lower frequencies in type 2 diabetes mellitus (T2DM) patients. GAD65Abs in T1DM patients are epitope specific, in contrast to those found in other GAD65Ab-positive individuals, including T2DM patients. Our aim was to assess whether epitope-specific GAD65Abs, or the additional presence of islet antigen 2 (IA-2) autoantibodies, better define T1DM phenotypes among T2DM patients. GAD65 and IA-2 autoantibodies were analyzed in 1436 Sardinian subjects classified with T2DM and in 384 nondiabetic patient controls. Autoantibody binding specificity to the N-terminal, middle (M), and C-terminal (C) portions of the GAD65 molecule was evaluated. Among the T2DM patients, 5.1% had GAD65 (P < 0.001) and 2.4% had IA-2 autoantibodies, compared with 1.3 and 1.6%, respectively, among the controls. GAD65Ab-positive T2DM patients with M+C (epitope-specific) (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Clinical Endocrinology and Metabolism
volume
89
issue
11
pages
5675 - 5682
publisher
Oxford University Press
external identifiers
  • scopus:8744245275
ISSN
1945-7197
DOI
10.1210/jc.2004-0864
language
English
LU publication?
no
id
ede405c6-e800-4e44-93ad-ff32aed80b24 (old id 1129986)
date added to LUP
2016-04-01 16:03:02
date last changed
2022-01-28 08:55:21
@article{ede405c6-e800-4e44-93ad-ff32aed80b24,
  abstract     = {{The 65-kDa glutamic acid decarboxylase (GAD65) autoantibodies (GAD65Abs), commonly found in type 1 diabetes mellitus (T1DM) patients, are also found at lower frequencies in type 2 diabetes mellitus (T2DM) patients. GAD65Abs in T1DM patients are epitope specific, in contrast to those found in other GAD65Ab-positive individuals, including T2DM patients. Our aim was to assess whether epitope-specific GAD65Abs, or the additional presence of islet antigen 2 (IA-2) autoantibodies, better define T1DM phenotypes among T2DM patients. GAD65 and IA-2 autoantibodies were analyzed in 1436 Sardinian subjects classified with T2DM and in 384 nondiabetic patient controls. Autoantibody binding specificity to the N-terminal, middle (M), and C-terminal (C) portions of the GAD65 molecule was evaluated. Among the T2DM patients, 5.1% had GAD65 (P &lt; 0.001) and 2.4% had IA-2 autoantibodies, compared with 1.3 and 1.6%, respectively, among the controls. GAD65Ab-positive T2DM patients with M+C (epitope-specific)}},
  author       = {{Maioli, Mario and Alejandro, Emilyn and Tonolo, Giancarlo and Gilliam, Lisa K. and Bekris, Lynn and Hampe, Christiane S. and Obinu, Domenica A and Manconi, Alberto and Puddu, Loreta and Lynch K, Kristian and Lernmark, Åke}},
  issn         = {{1945-7197}},
  language     = {{eng}},
  number       = {{11}},
  pages        = {{5675--5682}},
  publisher    = {{Oxford University Press}},
  series       = {{Journal of Clinical Endocrinology and Metabolism}},
  title        = {{Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.}},
  url          = {{http://dx.doi.org/10.1210/jc.2004-0864}},
  doi          = {{10.1210/jc.2004-0864}},
  volume       = {{89}},
  year         = {{2004}},
}